Advisor Group Holdings, Inc. Hoth Therapeutics, Inc. Transaction History

Advisor Group Holdings, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 04, 2022	BUY	$0.52 - $1.3 $52 - $130	100 Added 10000.0%	101 $453,000
Q3 2020 Nov 12, 2020	SELL	$1.86 - $3.15 $3 - $6	-2 Reduced 66.67%	1 $0
Q2 2020 Aug 14, 2020	BUY	$2.53 - $4.08 $7 - $12	3 New	3 $0

Ticker HOTH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,288,470
Market Cap $1.11M
Description
Hoth Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for unmet medical needs. It is involved in the development of HT-001, a topical formulation for the treatment of patients with rash and skin disorders associated with initial and repeat courses of tyrosine kinase epidermal growth factor receptor ...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.